Caribou Biosciences, Inc. (CRBU) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CRBU Revenue Growth
Revenue Breakdown (FY 2025)
CRBU's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
CRBU Revenue Analysis (2019–2025)
As of May 8, 2026, Caribou Biosciences, Inc. (CRBU) generated trailing twelve-month (TTM) revenue of $9.3 million, reflecting solid growth of +8.6% year-over-year. The most recent quarter (Q3 2025) recorded $2.2 million in revenue, down 17.6% sequentially.
Looking at the longer-term picture, CRBU's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $34.5 million in 2023.
Revenue diversification analysis shows CRBU's business is primarily driven by Reportable Segment (100%). With over half of revenue concentrated in Reportable Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including BEAM (+108.0% YoY), NTLA (+16.9% YoY), and CRSP (-88.9% YoY), CRBU has underperformed the peer group in terms of revenue growth. Compare CRBU vs BEAM →
CRBU Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CRBUCurrent | $9M | +8.6% | - | - | |
 BEAM | $140M | +108.0% | +466.3% | -274.6% | |
 NTLA | $68M | +16.9% | +3.1% | -651.7% | |
 CRSP | $4M | -88.9% | +37.3% | -16191.4% | |
 FATE | $7M | -51.2% | -26.7% | -2222.4% |
CRBU Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | -100.0% | $0 | - | $-148,344,000 | - |
| 2024 | $10.0M | -71.0% | $6.1M | 60.7% | $-166,616,000 | -1667.2% |
| 2023 | $34.5M | +148.9% | $31.0M | 89.8% | $-116,059,000 | -336.6% |
| 2022 | $13.9M | +44.3% | $10.2M | 73.7% | $-106,399,000 | -768.2% |
| 2021 | $9.6M | -22.4% | $8.6M | 89.7% | $-66,979,000 | -697.8% |
| 2020 | $12.4M | +113.6% | $-22,064,000 | -178.5% | $-36,124,000 | -292.2% |
| 2019 | $5.8M | - | $5.8M | 100.0% | $-34,305,000 | -592.7% |
See CRBU's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CRBU Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CRBU vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCRBU — Frequently Asked Questions
Quick answers to the most common questions about buying CRBU stock.
Is CRBU's revenue growth accelerating or slowing?
CRBU maintains +8.6% revenue growth, in line with its 5-year CAGR of N/A. TTM revenue stands at $9M. Growth rate remains consistent with historical average.
What is CRBU's long-term revenue growth rate?
Caribou Biosciences, Inc.'s 5-year revenue CAGR of N/A reflects the sustained expansion pattern. Current YoY growth of +8.6% is near this long-term average.
How is CRBU's revenue distributed by segment?
CRBU reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.